AVTR
Undervalued by 70.2% based on the discounted cash flow analysis.
Market cap | $9.25 Billion |
---|---|
Enterprise Value | $9.76 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $1.05 |
Beta | 1.05 |
Outstanding Shares | 681,100,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 12.92 |
---|---|
PEG | 190.27 |
Price to Sales | 6.87 |
Price to Book Ratio | 1.72 |
Enterprise Value to Revenue | 5.6 |
Enterprise Value to EBIT | 30.1 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.14 |
No data
No data
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.